Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 1/20 | 1.00 |
| ▸ | TSHR | P16473 | 2/20 | 0.58 |
| ▸ | BCHE | P06276 | 1/20 | 0.52 |
| ▸ | TRPC3 | Q13507 | 1/20 | 0.52 |
| ▸ | TRPC4 | Q9UBN4 | 1/20 | 0.52 |
| ▸ | TRPC5 | Q9UL62 | 1/20 | 0.52 |
| ▸ | SLC2A1 | P11166 | 4/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | CASR | P41180 | 1/20 | 0.41 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.41 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.41 |
| ▸ | PARP1 | P09874 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29489139 | 1.00 | BACE1 (1.00) | BACE1TSHRBCHETRPC3TRPC4 | |
| SCHEMBL29489140 | 1.00 | BACE1 (1.00) | BACE1TSHRBCHETRPC3TRPC4 | |
| Sulfuric Acid SCHEMBL29603231 | 0.94 | BACE1 (0.89) | BACE1TSHRBCHETRPC3TRPC4 | |
| Sulfuric Acid SCHEMBL30647443 | 0.94 | BACE1 (0.89) | BACE1TSHRBCHETRPC3TRPC4 | |
| Sulfuric Acid SCHEMBL29012236 | 0.94 | BACE1 (0.89) | BACE1TSHRBCHETRPC3TRPC4 | |
| Sulfuric Acid SCHEMBL25282862 | 0.94 | BACE1 (0.89) | BACE1TSHRBCHETRPC3TRPC4 | |
| Succinic Acid SCHEMBL29489142 | 0.93 | BACE1 (0.86) | BACE1TSHRBCHETRPC3TRPC4 | |
| Succinic Acid SCHEMBL25238080 | 0.93 | BACE1 (0.86) | BACE1TSHRBCHETRPC3TRPC4 | |
| Succinic Acid SCHEMBL29012249 | 0.93 | BACE1 (0.86) | BACE1TSHRBCHETRPC3TRPC4 | |
| Succinic Acid SCHEMBL29489143 | 0.93 | BACE1 (0.86) | BACE1TSHRBCHETRPC3TRPC4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 93 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4222144-B1 | SUCCINATE SALTS OF N-(3-(4-(3-(DIISOBUTYLAMINO)PROPYL)PIPERAZIN-1-YL)PROPYL)-1H-BENZO[D]IMIDAZOL-2-AMINE, PREPARATION THEREOF AND USE OF THE SAME | ALZPROTECT (FR) | 2026-05-20 | — | — | EP | claimed |
| US-12629368-B2 | Use of N-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1H-benzo[d]imidazol-2-amine sulphate salts and solvates thereof for the treatment of motor neuron diseases and neuromuscular junction disorders | ALZPROTECT (FR) | 2026-05-19 | — | — | US | claimed |
| US-20250205226-A1 | USE OF N-(3-(4-(3-(DIISOBUTYLAMINO)PROPYL)PIPERAZIN-1-YL)PROPYL)-1H-BENZO[D]IMIDAZOL-2-AMINE SALTS AND SOLVATES THEREOF FOR THE TREATMENT OF SENSORY NEURON DISEASES | ALZPROTECT (FR) | 2025-06-26 | — | — | US | claimed |
| EP-4225306-B1 | USE OF N-(3-(4-(3-(DIISOBUTYLAMINO)PROPYL)PIPERAZIN-1-YL)PROPYL)-1H-BENZO[D]IMIDAZOL-2-AMINE SULPHATE SALTS AND SOLVATES THEREOF FOR THE TREATMENT OF MOTOR NEURON DISEASES AND NEUROMUSCULAR JUNCTION DISORDERS | ALZPROTECT (FR) | 2025-02-12 | — | — | EP | claimed |
| US-20250041290-A1 | USE OF N-(3-(4-(3-(DIISOBUTYLAMINO)PROPYL)PIPERAZIN-1-YL)PROPYL)-1H-BENZO[d]IMIDAZOL-2-AMINE SUCCINATE SALTS AND SOLVATES THEREOF FOR THE TREATMENT OF MOTOR NEURON DISEASES AND NEUROMUSCULAR JUNCTION DISORDERS | ALZPROTECT (FR) | 2025-02-06 | — | — | US | claimed |
| US-20230391729-A1 | SUCCINATE SALTS OF N-(3-(4-(3-(DIISOBUTYLAMINO)PROPYL)PIPERAZIN-1-YL)PROPYL)-1H-BENZO[D]IMIDAZOL-2-AMINE, PREPARATION THEREOF AND USE OF THE SAME | ALZPROTECT (FR) | 2023-12-07 | — | — | US | claimed |
| US-20230364076-A1 | USE OF N-(3-(4-(3-(DIISOBUTYLAMINO)PROPYL)PIPERAZIN-1-YL)PROPYL)-1H-BENZO[D]IMIDAZOL-2-AMINE SULPHATE SALTS AND SOLVATES THEREOF FOR THE TREATMENT OF MOTOR NEURON DISEASES AND NEUROMUSCULAR JUNCTION DISORDERS | ALZPROTECT (FR) | 2023-11-16 | — | — | US | claimed |
| WO-2023180537-A1 | USE OF N-(3-(4-(3-(DIISOBUTYLAMINO)PROPYL)PIPERAZIN-1-YL)PROPYL)-1H-BENZO[D]IMIDAZOL-2-AMINE SALTS AND SOLVATES THEREOF FOR THE TREATMENT OF SENSORY NEURON DISEASES | ALZPROTECT (FR) | 2023-09-28 | — | — | WO | claimed |
| EP-4222144-A1 | SUCCINATE SALTS OF N-(3-(4-(3-(DIISOBUTYLAMINO)PROPYL)PIPERAZIN-1-YL)PROPYL)-1H-BENZO[D]IMIDAZOL-2-AMINE, PREPARATION THEREOF AND USE OF THE SAME | Alzprotect (FR) | 2023-08-09 | — | — | EP | claimed |
| CN-116419756-A | Use of N- (3- (4- (3- (diisobutylamino) propyl) piperazin-1-yl) propyl) -1H-benzo [ d ] imidazol-2-amine sulfate and solvates thereof for the treatment of motor neuron diseases and neuromuscular junction disorders | 雅尔兹普罗泰特公司 | 2023-07-11 | — | — | CN | claimed |
| WO-2023117990-A1 | USE OF N-(3-(4-(3-(DIISOBUTYLAMINO)PROPYL)PIPERAZIN-1-YL)PROPYL)-1H-BENZO[d]IMIDAZOL-2-AMINE SUCCINATE SALTS AND SOLVATES THEREOF FOR THE TREATMENT OF MOTOR NEURON DISEASES AND NEUROMUSCULAR JUNCTION DISORDERS | ALZPROTECT (FR) | 2023-06-29 | — | — | WO | claimed |
| CN-116249693-A | Succinate salt of N- (3- (4- (3- (diisobutylamino) propyl) piperazin-1-yl) propyl) -1H-benzo [ d ] imidazol-2-amine, preparation and use thereof | 雅尔兹普罗泰特公司 | 2023-06-09 | — | — | CN | claimed |
| US-10772884-B2 | Sulphate salts of N-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1H-benzo[d]imidazol-2-amine, preparation thereof and use of the same | ALZPROTECT (FR) | 2020-09-15 | — | — | US | claimed |
| US-20170151235-A1 | SULPHATE SALTS OF N-(3-(4-(3-(DIISOBUTYLAMINO)PROPYL)PIPERAZIN-1-YL)PROPYL)-1H-BENZO[d]IMIDAZOL-2-AMINE, PREPARATION THEREOF AND USE OF THE SAME | Université de Lille (FR) | 2017-06-01 | — | — | US | claimed |
| US-9562018-B2 | Sulphate salts of N-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1H-benzo[d]imidazol-2-amine, preparation thereof and use of the same | ALZPROTECT (FR) | 2017-02-07 | — | — | US | claimed |
| EP-2938597-B1 | SULPHATE SALTS OF N-(3-(4-(3-(DIISOBUTYLAMINO)PROPYL)PIPERAZIN-1-YL)PROPYL)-1H-BENZO[D]IMIDAZOL-2-AMINE, PREPARATION THEREOF AND USE OF THE SAME | ALZPROTECT (FR) | 2016-10-26 | — | — | EP | claimed |
| US-20160108003-A1 | SULPHATE SALTS OF N-(3-(4-(3-(DIISOBUTYLAMINO)PROPYL)PIPERAZIN-1-YL)PROPYL)-1H-BENZO[d]IMIDAZOL-2-AMINE, PREPARATION THEREOF AND USE OF THE SAME | Alzproject (FR) | 2016-04-21 | — | — | US | claimed |
| EP-4222144-B1 | SUCCINATE SALTS OF N-(3-(4-(3-(DIISOBUTYLAMINO)PROPYL)PIPERAZIN-1-YL)PROPYL)-1H-BENZO[D]IMIDAZOL-2-AMINE, PREPARATION THEREOF AND USE OF THE SAME | ALZPROTECT (FR) | 2026-05-20 | — | — | EP | disclosed |
| EP-1809288-A1 | USE OF 1,4-BIS (3-AMINOALKYL) PIPERAZINE DERIVATIVES IN THE TREATMENT OF NEURODEGENERATIVE DISEASES | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) | 2007-07-25 | — | — | EP | disclosed |
| WO-2006051489-A1 | USE OF 1,4-BIS (3-AMINOALKYL) PIPERAZINE DERIVATIVES IN THE TREATMENT OF NEURODEGENERATIVE DISEASES | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) | 2006-05-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230391729-A1 | SUCCINATE SALTS OF N-(3-(4-(3-(DIISOBUTYLAMINO)PROPYL)PIPERAZIN-1-YL)PROPYL)-1H-BENZO[D]IMIDAZOL-2-AMINE, PREPARATION THEREOF AND USE OF THE SAME | SDHA, SDHB, SUCNR1 | BACE1 635/4885TSHR 4792/4885BCHE 1797/4885 |
| US-20160108003-A1 | SULPHATE SALTS OF N-(3-(4-(3-(DIISOBUTYLAMINO)PROPYL)PIPERAZIN-1-YL)PROPYL)-1H-BENZO[d]IMIDAZOL-2-AMINE, PREPARATION THEREOF AND USE OF THE SAME | PRNP, PSEN2, PSEN1 | BACE1 74/4885TSHR 4036/4885BCHE 1168/4885 |
| US-20170151235-A1 | SULPHATE SALTS OF N-(3-(4-(3-(DIISOBUTYLAMINO)PROPYL)PIPERAZIN-1-YL)PROPYL)-1H-BENZO[d]IMIDAZOL-2-AMINE, PREPARATION THEREOF AND USE OF THE SAME | PRNP, PSEN2, PSEN1 | BACE1 74/4885TSHR 4036/4885BCHE 1168/4885 |
| US-20250041290-A1 | USE OF N-(3-(4-(3-(DIISOBUTYLAMINO)PROPYL)PIPERAZIN-1-YL)PROPYL)-1H-BENZO[d]IMIDAZOL-2-AMINE SUCCINATE SALTS AND SOLVATES THEREOF FOR THE TREATMENT OF MOTOR NEURON DISEASES AND NEUROMUSCULAR JUNCTION DISORDERS | SMN1; SMN2, NLN, SDHA | BACE1 2104/4885TSHR 4607/4885BCHE 1025/4885 |
| US-12629368-B2 | Use of N-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1H-benzo[d]imidazol-2-amine sulphate salts and solvates thereof for the treatment of motor neuron diseases and neuromuscular junction disorders | SMN1; SMN2, MUSK, SNCA | BACE1 2112/4885TSHR 1990/4885BCHE 2085/4885 |
| US-10772884-B2 | Sulphate salts of N-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1H-benzo[d]imidazol-2-amine, preparation thereof and use of the same | PRNP, PSEN2, PSEN1 | BACE1 74/4885TSHR 4036/4885BCHE 1168/4885 |
| US-20230364076-A1 | USE OF N-(3-(4-(3-(DIISOBUTYLAMINO)PROPYL)PIPERAZIN-1-YL)PROPYL)-1H-BENZO[D]IMIDAZOL-2-AMINE SULPHATE SALTS AND SOLVATES THEREOF FOR THE TREATMENT OF MOTOR NEURON DISEASES AND NEUROMUSCULAR JUNCTION DISORDERS | SMN1; SMN2, INA, SCN3A | BACE1 1144/4885TSHR 4224/4885BCHE 567/4885 |
| US-20250205226-A1 | USE OF N-(3-(4-(3-(DIISOBUTYLAMINO)PROPYL)PIPERAZIN-1-YL)PROPYL)-1H-BENZO[D]IMIDAZOL-2-AMINE SALTS AND SOLVATES THEREOF FOR THE TREATMENT OF SENSORY NEURON DISEASES | NLN, SCN3A, INA | BACE1 812/4885TSHR 3652/4885BCHE 1289/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.